Anti-Nociceptive Effect of Octreotide, a Somatostatin Analogue in Acute Inflammatory Pain in Rats
Journal Title: The 2nd Annual Meeting of International Center for Neuroscience Research - Year 2021, Vol 2, Issue 1
Abstract
Background: Opiates like morphine are used for the treatment of moderate to severe pain. However long-term use often leads to adverse effects like dependence and tolerance. Thus, newer analgesics with lesser side effects need to be identified. Somatostatin is an inhibitory neurotransmitter which is expressed at spinal level where it modulates the transmission of pain. Unfortunately somatostatin has very short half-life. In the present study, the antinociceptive effect of octreotide (a more stable synthetic analog of somatostatin) was evaluated in acute inflammatory pain in rats. Materials and methods: Adult male Sprague-Dawley rats were divided into three equal groups (n=6/group). Acute inflammatory pain was induced by intraplantar administration of carrageenan. Octreotide (3µg) and morphine (10mg/kg) was administered 2 h after the carrageenan in the thigh on the same side. Mechanical allodynia was measured by von Frey filaments at the site of inflammation at 1 and 2 h of drug administration. Paw odema due to carrageenan was evaluated by the plethysmometer at 2 h of drug administration. The rat activity was examined at same time intervals by using activity monitor. Expression of Somatostatin type 2 receptor (SSTR2) was observed at the lumbar region (L4-L5) of the spinal cord. Results: The dose of octreotide was standardized initially by administration of 3µg, 10µg, 30µg &100µg and measuring the corresponding anti-nociceptive effect. The 3µg dose was finally selected due to optimum effect and absence of adverse reactions. Octreotide decreased allodynia compared saline treated control group. However paw odema was not affected by any of the drugs. Importantly nociception returned to baseline values after administration of morphine. Conclusion: The results show that a low dose of octreotide is effective in reducing nociception, compared to higher doses. However, this anti-nociceptive was not as much as morphine which is considered to be the gold standard drug for pain relief. Our finding is supported by other studies which have also observed antinociception in rodents. This information may have clinical relevance.
Authors and Affiliations
Perminder Singh* and S. B. Ray
Keywords
Related Articles
- EP ID EP701742
- DOI -
- Views 81
- Downloads 0
The Beneficial Potential of Human Dental Pulp Stem Cells and their Conditioned Medium in the Treatment of Rat Model of Ischemic Stroke
Dental pulp stem cells (DPSCs) are considered as a promising type of stem cells for cell-based therapies. Hence, in this study we assessed the therapeutic effects of human (h)DPSCs and their conditioned medium (CM) in a...
Role of miR-29b in Rotenone-Induced Mitochondrial Dysfunction in Neuronal Cells
Pesticides toxicity has become a global concern owing to its adverse pathophysiological effect and neurotoxic potential. Rotenone exposure represents a major public health concern that causes a variety of neurological...
Targeted Delivery of Quercetin-Loaded Magnetic Nanoparticles Decrease Seizure Activity and Ameliorate Kainate-Induced Memory Disturbances in the Animal Models of Epilepsy
Epilepsy is chronic neurological disease affecting roughly 1% of the human population. It is characterized by periodic repetitive seizures and associated cognitive impairments. Almost 30% of epileptic cases are refracto...
The Effects of Myricitrin on the Brain Edema, Neurological Scores and Blood-Brain Barrier Permeability, after Severe Traumatic Brain Injury in Male Rat: The Role of Matrix Metallopeptidase-9
Introduction: Brain trauma is one of the leading causes of death among young people worldwide today and one of the leading causes of hospitalization. Myricitrin (Myr) is a natural compound, a flavonoid glycoside, which...
Altering TGF-β signaling pathway: An approach to halt pentylenetetrazole-induced epileptogenesis in mice
Epilepsy is illustrated by persistent predisposition of the brain to generate seizures and considered as one of the most common, chronic, neurological disorder affecting around 1% of the individuals worldwide. A growing...